ASCT Viewpoint
Apr. 8, 2015

Is bevacizumab truly a new standard in cervical cancer?
Medscape
Adding bevacizumab (Avastin, Genentech/Roche) to chemotherapy in the treatment of advanced cervical cancer was hailed as practice changing when it showed a survival benefit in a landmark trial. But questions about the combination and quality of life remain because the addition of bevacizumab increases the toxicity of the treatment.More

Registration is now open for the 2015 ASCT Annual Conference
ASCT

May 1-3, 2015
Sheraton Hotel
Nashville, Tennessee


Click here for detailed information and registration
More

The American Society for Cytotechnology celebrates Medical Laboratory Professionals Week
ASCT
April 19-25, 2015

Medical Laboratory Professionals Week is an annual celebration of all laboratory personnel who play a critical role in every aspect of health care. Lab Week is the perfect time to honor the more than 300,000 medical laboratory professionals who work behind the scenes performing and interpreting more than 10 billion laboratory tests in the US per year. ASCT is proud to be one of 14 organizations that sponsor this important week in giving thanks to all laboratory professionals for their dedication to quality patient care.More

Women with IBD may face higher cervical cancer risk
Healio
A diagnosis of inflammatory bowel disease in women was found to be associated with increased risk for cervical neoplasia in a population-based nationwide cohort study. "Our research shows that patients with IBD, specifically Crohn's disease, are at increased risk for developing cervical cancer, even when undergoing the recommended screening," Tine Jess, M.D., from Statens Serum Institut in Denmark, said in a press release. "These findings provide an important reminder for IBD patients, and their physicians, to follow the recommended screening guidelines for cervical cancer." More

Why some HPV infections go away and others become cancer
Medical Xpress
For people infected with the human papilloma virus (HPV), the likelihood of clearing the infection and avoiding HPV-related cancer may depend less on the body's disease-fighting arsenal than has been generally assumed. A new study finds that the body's ability to defeat the virus may be largely due to unpredictable division patterns in HPV-infected stem cells, rather than the strength of the person's immune response. More

Antiviral promising in early HPV trial
Medscape
The experimental antiviral drug ranpirnase can completely clear away the warts caused by human papillomavirus (HPV), a preliminary study has shown. If these results are borne out in further studies, ranpirnase would be the first drug to attack HPV itself, said Eric Daniels, M.D., a research consultant for Tamir Biotechnology in San Diego.More

Hope for cervical cancer patients thanks to laser that can spot the disease early
Daily Mail
Laser beams could help detect cervical cancer at an early stage, say researchers from China. The new technique involves firing pulses of light, more of which is absorbed by cancerous cells than by healthy tissue. The way the cancer cells react to the light means they can then be picked up on an ultrasound scan. The scan can show not only if someone has the disease, but also potentially how advanced it is. More

Accuracy is critical in cervical cancer tests
Chron.com
A recent study showing that the HPV test is more accurate than the traditional Pap smear has started a conversation among doctors about what a well-woman exam should include. Researchers at the University of Alabama found that the HPV test is far more accurate than the traditional Pap smear that's been used by physicians for the past 80 years to check for cervical cancer. More

Carboplatin noninferior to cisplatin for metastatic, recurrent cervical cancer
Healio
Carboplatin-based chemotherapy should be a standard treatment option for metastatic or recurrent cervical cancer, according to findings from a randomized phase 3 trial. Palliative chemotherapy is an option for women with metastatic or recurrent cervical cancer. Cisplatin has been the active agent most often used in that setting. More

Your microbiome may hold keys to cancer treatment
Popular Science
Today, the field of oncology is exploring new and diverse ways to fight cancer, from antibodies to vaccines to cracking the genetic code. All of these biological elements affect how cancer starts and how doctors can treat it. But according to a review published today in Science, the bacteria living in and around our bodies may hold keys to more effective cancer treatment in the near future. More